LONDON: Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, today notes the Regional Ministry of Health for Aragon, Spain has announced that the Company’s Early CDT Lung blood test is to be adopted by the Thoracic Surgery Unit of the University Hospital Miguel Servet, Zaragoza, for use on solitary pulmonary nodules. This approval…